Key statistics
On Tuesday, Sonnet Biotherapeutics Holdings Inc (SONN:NAQ) closed at 4.88, 6.37% above its 52-week low of 4.59, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.88 |
---|---|
High | 5.00 |
Low | 4.66 |
Bid | 4.71 |
Offer | 4.92 |
Previous close | 4.70 |
Average volume | 25.39k |
---|---|
Shares outstanding | 650.31k |
Free float | 614.93k |
P/E (TTM) | -- |
Market cap | 3.06m USD |
EPS (TTM) | -24.17 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
- Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
- Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
- Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
- Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
More ▼